Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI

This preliminary descriptive report compares the rates of detecting high- and low-grade prostate cancer in men invited for prostate cancer screening vs

Related Keywords

Helsinki ,Eteläuomen Läi ,Finland ,Paris ,France General ,France ,United Kingdom ,Ronkainen ,Northern Ostrobothnia ,Sweden ,Carvo ,Kainuu Region ,Tammela ,Kanta Hame Region ,Riikonen ,Rannikko ,Southwest Finland ,Swedish ,Finnish ,Anssi Auvinen ,Participantsthe Proscreen ,Fimlab Tampere ,Radiopharm Theranostics ,Ethics Committee Of The Helsinki University Hospital ,Wallenberg Research ,Us National Cancer Institute ,Amgen ,World Health Organization ,Academy Of Finland ,Health Sciences ,Perkinelmer ,National Institute For Health ,International Society For Urological Pathology ,Helsinki University Hospital ,Finland State Research Funding ,Janssen Pharmaceuticals ,Kallikrein Panel ,Tampere University Hospital ,European Association Of Urology ,Tampere University ,Aatos Erkko Foundation ,Lund University ,Health Inc ,Philips ,Sakari Sohlberg Foundation ,Population Data Services Agency ,Orion Corp ,Finnish Cancer Foundation ,Swedish Cancer Society ,University Hospital In Malm ,Fujirebio Diagnostics Inc ,Group Information ,Ethics Committee ,National Institute ,Finnish Cancer Registry ,University Hospital ,Cancer Outcomes ,Prostate Imaging Reporting ,Data System ,International Society ,Urological Pathology ,Size Calculation ,All Participants Randomized ,Control Group ,Analyses With Imputation ,Missing Values ,Per Protocol Analysis ,European Randomized Study ,Prostate Cancer ,United Kingdom Cluster Randomized Trial ,Drs Auvinen ,Interest Disclosures ,Tay Ja Tays ,Arctic Partners ,Sigrid Jus ,Sakari Sohlberg ,Cancer Institute ,Swedish Cancer ,Proscreen Trial Investigators ,European Association ,